Solvay Launches ISCC PLUS Certified Mass Balance HQ, HQ Monomethylether

Solvay has announced that the production of its hydroquinone (HQ) and hydroquinone monomethylether (MeHQ) in Saint-Fons, France has been accredited to comply with the mass balance accounting regime of the International Sustainability and Carbon Certification (ISCC) PLUSsystem*. HQ and MeHQ (also referred to as para-methoxyphenol, PMP) are frequently used as building blocks in the formulation of polyetherether ketone (PEEK), liquid crystal polymer (LCP) and other high-performance engineering thermoplastics. They also serve as raw materials in epoxy and polyester coatings, in polyurethane adhesives, and as inhibitors for monomer stabilization during production, storage and transportation. “As a leading producer of HQ and MeHQ, offering mass balance certified grades exemplifies our strategic commitment to drive the change towards high-quality, sustainable solutions as the polymer and chemicals industry is transforming from a linear to a more circular economy,” said Jo Grosemans, Solvay natural growth director. * Mass balance accounting according to the ISCC PLUS regime has become a globally acknowledged industry standard that defines a clear set of rules for tracking and tracing the content of circular and renewable feedstock in materials and end products. As a result, users of certified materials across the entire value chain can claim a measurably reduced carbon footprint for their formulations.
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.